Overexpression of GDP dissociation inhibitor 1 gene associates with the invasiveness and poor outcomes of colorectal cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Lucas C, Barnich N, Nguyen HTT. Microbiota, Inflammation and colorectal cancer. Int J Mol Sci. 2017;18(6):1310.
   Web of Science ®Google Scholar
• Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell. 2018;9(5):474–487.
   PubMed Web of Science ®Google Scholar
• Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18(8):e457–e471.
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Itzkowitz SH, Longo DL. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441–1452.
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15:111–128.
   PubMed Web of Science ®Google Scholar
• Coppede F, Lopomo A, Spisni R, et al. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol. 2014;20(4):943–956. .
   PubMed Web of Science ®Google Scholar
• Koga Y, Yasunaga M, Moriya Y, et al. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis. Cancer Sci. 2008;99:1977–1983.
   PubMed Web of Science ®Google Scholar
• Koga Y, Yasunaga M, Takahashi A, et al. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila). 2010;3(11):1435–1442. .
   PubMed Web of Science ®Google Scholar
• Link A, Balaguer F, Shen Y, et al. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1766–1774. .
   PubMed Web of Science ®Google Scholar
• Wang JY, Wu CH, Lu CY, et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg. 2006;30(6):1007–1013. .
   PubMed Web of Science ®Google Scholar
• Shen C, Hu L, Xia L, et al. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Jpn J Clin Oncol. 2008;38(11):770–776. .
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127(1):118–126. .
   PubMed Web of Science ®Google Scholar
• Lech G, Słotwiński R, Słodkowski M, et al. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J Gastroenterol. 2016;22(5):1745–1755. .
   PubMed Web of Science ®Google Scholar
• Labianca R, Nordlinger B, Beretta GD, et al. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v70–77. .
   PubMed Web of Science ®Google Scholar
• Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–5327. .
   PubMed Web of Science ®Google Scholar
• Nicolini A, Ferrari P, Duffy MJ, et al. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival. Arch Surg. 2010;145(12):1177–1183. .
   PubMedGoogle Scholar
• Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the diagnosis of recurrent colorectal cancer. Tumour Biol. 2004;25(5–6):228–234. .
   PubMedGoogle Scholar
• Jacob S, Ng W, Asghari R, et al. Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilization. Clin Colorectal Cancer. 2011;10(2):102–107. .
   PubMed Web of Science ®Google Scholar
• Muller MP, Goody RS. Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases. 2018;9(1–2):5–21.
   PubMedGoogle Scholar
• Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev. 2011;91(1):119–149.
   PubMed Web of Science ®Google Scholar
• Lamber EP, Siedenburg AC, Barr FA. Rab regulation by GEFs and GAPs during membrane traffic. Curr Opin Cell Biol. 2019;59:34–39.
   PubMed Web of Science ®Google Scholar
• Takai YST, Matozakin T, Matozaki T. Small GTP -binding proteins. Physiol Rev. 2001;81(1):153–208.
   PubMed Web of Science ®Google Scholar
• Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513–525.
   PubMed Web of Science ®Google Scholar
• Wheeler DZR, Root DE. Identification of an Oncogenic RAB protein Science. 2015;350:211–217. Identification of an Oncogenic RAB prorein.
   Google Scholar
• Ge J, Ge C. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer. Virchows Arch. 2019;474(1):59–69.
   PubMed Web of Science ®Google Scholar
• Driehuis E, Clevers H. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer. Br J Pharmacol. 2017;174(24):4547–4563.
   PubMed Web of Science ®Google Scholar
• Xu DD, Xu CB, Lam HM, et al. Proteomic analysis reveals that pheophorbide a-mediated photodynamic treatment inhibits prostate cancer growth by hampering GDP-GTP exchange of ras-family proteins. Photodiagnosis Photodyn Ther. 2018;23:35–39.
   PubMed Web of Science ®Google Scholar
• Ming Z, Guo C, Jiang M, et al. Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer. Diagn Pathol. 2014;9(1):201. .
   PubMed Web of Science ®Google Scholar
• Kamal AH, Han BS, Choi JS, et al. Proteomic analysis of the effect of retinoic acids on the human breast cancer cell line MCF-7. Mol Biol Rep. 2014;41(5):3499–3507.
   PubMed Web of Science ®Google Scholar
• Wan M, Francke U. Evaluation of two X chromosomal candidate genes for Rett syndrome: glutamate dehydrogenase-2 (GLUD2) and rab GDP-dissociation inhibitor (GDI1). Am J Med Genet. 1998;78(2):169–172.
   PubMed Web of Science ®Google Scholar
• Orlando R, Borro M, Motolese M, et al. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740. Neuropharmacology. 2014;86:133–144.
   PubMed Web of Science ®Google Scholar
• Duan Y, Lin S, Xie L, et al. Exome sequencing identifies a novel mutation of the GDI1 gene in a Chinese non-syndromic X-linked intellectual disability family. Genet Mol Biol. 2017;40(3):591–596.
   PubMed Web of Science ®Google Scholar
• Ishizaki H, Miyoshi J, Kamiya H, et al. Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission. Proc Natl Acad Sci U S A. 2000;97(21):11587–11592.
   PubMed Web of Science ®Google Scholar
• D’adamo P, Masetti M, Bianchi V, et al. RAB GTPases and RAB-interacting proteins and their role in the control of cognitive functions. Neurosci Biobehav Rev. 2014;46(Pt 2):302–314. .
   PubMed Web of Science ®Google Scholar
• Bianchi V, Gambino F, Muzio L, et al. Forebrain deletion of αGDI in adult mice worsens the pre-synaptic deficit at cortico-lateral amygdala synaptic connections. PLoS One. 2012;7(1):e29763. .
   PubMed Web of Science ®Google Scholar
• Chen S, Wei Y, Liu H, et al. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics. Bioengineered. 2021;12(1):127–137.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang H, Lai L, et al. Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers. Clin Sci (Lond). 2013;124(9):567–578.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xin Y, Li R, et al. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer. Gene. 2014;537(2):253–259.
   PubMed Web of Science ®Google Scholar
• Rane CK, Minden A. P21 activated kinases: structure, regulation, and functions. Small GTPases. 2014;5.
   Google Scholar
• Zhao ZS, Manser E. PAK family kinases: physiological roles and regulation. Cell Logist. 2012;2(2):59–68.
   PubMedGoogle Scholar
• Cotteret S, Chernoff J. The evolutionary history of effectors downstream of Cdc42 and Rac. Genome Biol. 2002;3(2). Reviews0002.
   PubMed Web of Science ®Google Scholar
• Moon SY, Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 2003;13(1):13–22.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Yamamoto E, Yamano HO, et al. Integrated Analysis of the endoscopic, pathological and molecular characteristics of colorectal tumorigenesis. Digestion. 2019;99(1):33–38. .
   PubMed Web of Science ®Google Scholar
• Koliaraki V, Pallangyo CK, Greten FR, et al. Mesenchymal Cells in Colon Cancer. Gastroenterology. 2017;152(5):964–979. .
   PubMed Web of Science ®Google Scholar
• Fang L, Lu W, Choi HH, et al. ERK2-Dependent phosphorylation of CSN6 is critical in colorectal cancer development. Cancer Cell. 2015;28(2):183–197.
   PubMed Web of Science ®Google Scholar